| Product Code: ETC7542914 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The etoricoxib intermediate market import shipments in India showed a steady upward trajectory from 2020 to 2024, with a notable CAGR of 7.1%. However, the growth rate experienced a sharp decline of -33.1% between 2023 and 2024, indicating a significant slowdown in market expansion in the recent period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Etoricoxib Intermediate Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Etoricoxib Intermediate Market Revenues & Volume, 2021 & 2031F |
3.3 India Etoricoxib Intermediate Market - Industry Life Cycle |
3.4 India Etoricoxib Intermediate Market - Porter's Five Forces |
3.5 India Etoricoxib Intermediate Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Etoricoxib Intermediate Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 India Etoricoxib Intermediate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for pharmaceutical products in India |
4.2.2 Growth in the healthcare sector and increasing focus on research and development |
4.2.3 Government initiatives to promote domestic pharmaceutical manufacturing |
4.3 Market Restraints |
4.3.1 Stringent regulations and compliance requirements in the pharmaceutical industry |
4.3.2 Competition from other countries in the pharmaceutical intermediate market |
4.3.3 Fluctuating raw material prices and supply chain challenges |
5 India Etoricoxib Intermediate Market Trends |
6 India Etoricoxib Intermediate Market, By Types |
6.1 India Etoricoxib Intermediate Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Etoricoxib Intermediate Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Etoricoxib Intermediate Market Revenues & Volume, By In-House Manufacturing, 2021- 2031F |
6.1.4 India Etoricoxib Intermediate Market Revenues & Volume, By Contract Manufacturing Organizations, 2021- 2031F |
6.2 India Etoricoxib Intermediate Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 India Etoricoxib Intermediate Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.2.3 India Etoricoxib Intermediate Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.2.4 India Etoricoxib Intermediate Market Revenues & Volume, By Acute Pain, 2021- 2031F |
6.2.5 India Etoricoxib Intermediate Market Revenues & Volume, By Others, 2021- 2031F |
7 India Etoricoxib Intermediate Market Import-Export Trade Statistics |
7.1 India Etoricoxib Intermediate Market Export to Major Countries |
7.2 India Etoricoxib Intermediate Market Imports from Major Countries |
8 India Etoricoxib Intermediate Market Key Performance Indicators |
8.1 Research and development investment in pharmaceutical sector |
8.2 Number of new drug approvals in India |
8.3 Adoption rate of advanced manufacturing technologies in pharmaceutical industry. |
9 India Etoricoxib Intermediate Market - Opportunity Assessment |
9.1 India Etoricoxib Intermediate Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Etoricoxib Intermediate Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 India Etoricoxib Intermediate Market - Competitive Landscape |
10.1 India Etoricoxib Intermediate Market Revenue Share, By Companies, 2024 |
10.2 India Etoricoxib Intermediate Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here